ArticleFrontiers in immunology2026

The application of rituximab during the conditioning regimen prevents Epstein - Barr virus infection following rATG-based haploidentical hematopoietic stem cell transplantation in the era of letermovir for cytomegalovirus prophylaxis.

Jinxia Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.